Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR-Reference-Cited by-同舟云学术

Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR

Published:2010-01 Issue:1-2 Volume:160 Page:8-19
ISSN:0043-5341
Container-title:Wiener Medizinische Wochenschrift
language:en
Short-container-title:Wien Med Wochenschr

Author:

Schernthaner Guntram

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10354-010-0748-7.pdf

Reference66 articles.

1. Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet, 368: 1681–1688, 2006

2. Schernthaner G. Cardiovascular mortality and morbidity in type-2 diabetes mellitus. Diabetes Res Clin Pract, 31(Suppl): S3–S13, 1996

3. Preis SR, Hwang SJ, Coady S, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation, 119: 1728–1735, 2009

4. Turner R, Millns H, Neil H, et al. Risk factors for coronary artery disease in non-insulin dependant diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23). BMJ, 316: 823–828, 1998

5. The DECODE Study Group, on behalf of the European Diabetes Epidemiology Group. Is the current definition of diabetes relevant to mortality risk from all causes and cardiovascular and non-cardiovascular diseases? Diabetes Care, 26: 688–696, 2003

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world effectiveness of early insulin therapy on the incidence of cardiovascular events in newly diagnosed type 2 diabetes;Signal Transduction and Targeted Therapy;2024-06-06

2. Diabetestherapie bei herzkranken Patienten;Diabetes aktuell;2023-05

3. Diabetestherapie bei herzkranken Patienten;Diabetologie und Stoffwechsel;2023-02

4. 2022 Summary of recommendations for long-term secondary prevention after myocardial infarction;Cor et Vasa;2022-02-02

5. Nephropathie bei Diabetes;CardioVasc;2021-06